Metin Kurtoğlu
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 10%
- Metabolism, Diabetes, and Cancer
- Mitochondrial Function and Pathology
- ATP Synthase and ATPases Research
- Epigenetics and DNA Methylation
Papers in
-
- Cancer, Hypoxia, and Metabolism 13
-
- Viral Infectious Diseases and Gene Expression in Insects 4
- Mitochondrial Function and Pathology 2
- Co-authors
- Théodore J. Lampidis (19 shared papers)Johnathan C. Maher (7 shared papers)Medhi Wangpaichitr (6 shared papers)Niramol Savaraj (6 shared papers)Haibin Xi (4 shared papers)Mert Erkan (3 shared papers)Huaping Liu (7 shared papers)Jörg Kleeff (2 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (7 papers)Blood (4 papers)Cancer Research (3 papers)Molecular Cancer Therapeutics (3 papers)Pancreatology (1 paper)
- Partner nations
- United StatesTürkiyeUnited Kingdom
In The Last Decade
Metin Kurtoğlu
37 papers receiving 2.1k citations
Metin Kurtoğlu's Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 736
- Molecular Biology 1.1k
- Oncology 388
- Hematology 120
- Cell Biology 178
Countries citing papers authored by Metin Kurtoğlu
This map shows the geographic impact of Metin Kurtoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Metin Kurtoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Metin Kurtoğlu more than expected).
Fields of papers citing papers by Metin Kurtoğlu
This network shows the impact of papers produced by Metin Kurtoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Metin Kurtoğlu. The network helps show where Metin Kurtoğlu may publish in the future.
Co-authors
The 25 scholars most cited alongside Metin Kurtoğlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors Hit paper breakdown → | 2012 | 424 |
| 2 | 2007 | 203 | |
| 3 | 2010 | 165 | |
| 4 | 2007 | 131 | |
| 5 | 2015 | 124 | |
| 6 | 2011 | 104 | |
| 7 | 2010 | 95 | |
| 8 | 2007 | 92 | |
| 9 | 2014 | 92 | |
| 10 | 2010 | 74 | |
| 11 | 2006 | 68 | |
| 12 | 2020 | 66 | |
| 13 | 2010 | 65 | |
| 14 | 2008 | 52 | |
| 15 | 2012 | 44 | |
| 16 | 2013 | 42 | |
| 17 | 2009 | 35 | |
| 18 | 2021 | 31 | |
| 19 | 2008 | 30 | |
| 20 | 2016 | 23 |
About Metin Kurtoğlu
Metin Kurtoğlu is a scholar working on Cancer Research, Molecular Biology, Oncology, Cell Biology and Epidemiology, having authored 39 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (13 papers), Endoplasmic Reticulum Stress and Disease (6 papers), CAR-T cell therapy research (5 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), Autophagy in Disease and Therapy (4 papers), Cancer-related Molecular Pathways (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Mitochondrial Function and Pathology (2 papers). The work is most often cited by research in Cancer Research (736 citations), Molecular Biology (1.1k citations), Oncology (388 citations), Hematology (120 citations) and Cell Biology (178 citations). Metin Kurtoğlu has collaborated with scholars based in United States, Türkiye and United Kingdom. Frequent co-authors include Théodore J. Lampidis, Johnathan C. Maher, Medhi Wangpaichitr, Niramol Savaraj, Haibin Xi, Mert Erkan, Huaping Liu, Jörg Kleeff, Ningguo Gao and Mark A. Lehrman. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Blood, Cancer Research, Molecular Cancer Therapeutics and Pancreatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.